IMPROVEMENT IN ACCURACY OF DELAYED RECALL IN AGED AND NON-AGED, MATURE MONKEYS AFTER INTRAMUSCULAR OR TRANSDERMAL ADMINISTRATION OF THE CNSNICOTINIC RECEPTOR AGONIST ABT-418
Ma. Prendergast et al., IMPROVEMENT IN ACCURACY OF DELAYED RECALL IN AGED AND NON-AGED, MATURE MONKEYS AFTER INTRAMUSCULAR OR TRANSDERMAL ADMINISTRATION OF THE CNSNICOTINIC RECEPTOR AGONIST ABT-418, Psychopharmacology, 130(3), 1997, pp. 276-284
ABT-418 was evaluated for its ability to enhance accuracy on a delayed
matching-to-sample (DMTS) task by aged monkeys following intramuscula
r administration, and in non-aged mature monkeys following transdermal
application. Aged monkeys were impaired in their performance of the D
MTS task such that the longest delay intervals performed at above-chan
ce levels extended only to 20 s. In contrast, for non-aged, mature ani
mals, delay intervals extended to 140 s. In aged monkeys, the response
to ABT-418 was highly individualized with animals responding to one o
r more doses in the range of 2-259 nmol/kg. A systematic dose-dependen
t enhancement of DMTS accuracy was not observed. When the individualiz
ed ''best dose'' was administered on a separate occasion, overall DMTS
accuracy was increased by 12.6%. By 24 h after administration, accura
cy was at control levels, In young monkeys, a significant dose-depende
nt enhancement of DMTS performance (an overall increase of 11.25% abov
e baseline accuracy) was observed 5 h after application of a transderm
al patch designed to maintain steady-state plasma levels of ABT-418 of
40-60 ng/ml over a 24-h period. Again there was some individual respo
nsiveness to one of the three doses. When data included only the indiv
idualized best doses of ABT-418 for each animal, a similar enhancement
of accuracy was observed for both the 5-h and 24-h test intervals. In
neither the aged nor the young cohorts was enhancement of performance
associated with altered response latencies or with any overt side eff
ects of ABT-418. Thus, these data are consistent with the ability of A
BT-418 to improve DMTS performance in both young and aged monkeys. In
aged monkeys, this response was observed only after administration of
individualized optimal doses for different monkeys. In young monkeys,
a more systematic enhancement of DMTS accuracy was observed. Further,
transdermal delivery of ABT-418 in non-aged monkeys demonstrated prolo
nged performance enhancement compared with IM injection to at least 24
h after patch administration.